A Phase I-Ii, Open-Label, Multicenter Trial to Determine the Dosimetry and Safety of 99mTc-Sestamibi in Pediatric Subjects
Journal of Nuclear Medicine - China
doi 10.2967/jnumed.114.146795
Full Text
Open PDFAbstract
Available in full text
Date
April 9, 2015
Authors
Publisher
Society of Nuclear Medicine